SCHEDULE 3INFORMATION TO BE INCLUDED IN AN APPLICATION FOR CONSENT TO MARKET GENETICALLY MODIFIED ORGANISMS
Part IGENERAL INFORMATION
1
The proposed commercial name of the product and names of the genetically modified organisms in the product, F1the unique identifier assigned in accordance with Regulation 65/2004, and any other, name or code used by the applicant to identify the genetically modified organism.
2
The name and address in the Community of the person who is responsible for the placing on the market, whether it be the manufacturer, importer or distributor.
3
The name and address of the supplier or suppliers of control samples.
4
A description of how the product and the genetically modified organism are intended to be used, highlighting any differences in use or management of the genetically modified organism compared to similar non-genetically modified products.
5
A description of the geographical area or areas and types of environment where the product is intended to be used within the Community, including, where possible, an estimate of the scale of use in each area.
6
A description of the intended categories of users of the product, such as industry, agriculture or consumer use by the public.
F27
1
Information on—
a
methods for the detection, identification and, where appropriate, quantification of the transformation event,
b
samples of the genetically modified organisms and their control samples,
c
the place where the reference material can be accessed.
2
Information under sub-paragraph (1) that cannot be placed on the register for confidentiality reasons, must be identified.
8
The proposed labelling, which must include, in a label or an accompanying document, at least in summarised form, a commercial name of the product, a statement that “This product contains genetically modified organisms”, the name of the genetically modified organism and the name and address of the person established in the Community who is responsible for the placing on the market, and how to access the information in the publicly accessible part of the register.
Part IIADDITIONAL RELEVANT INFORMATION
9
The measures to be taken in the event of the escape of the organisms in the product or misuse of the product.
10
Specific instructions or recommendations for storage and handling of the product.
11
Specific instructions for carrying out monitoring and reporting to the applicant and, if required, the National Assembly for Wales, which are consistent with Part C of Annex VII of the Deliberate Release Directive.
12
The proposed restrictions in the approved use of the genetically modified organism, such as where the product may be used and for what purposes.
13
The proposed packaging.
14
The estimated product in and/or imports to the Community.
15
Any proposed additional labelling, which may include, at least in summarised form, the information referred to in paragraphs 4 and 5 of Part I of this Schedule, or paragraphs 9 to 12 of this Part.